Geraint Jenkins

Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex

M. Gravenor, A. John, J. Halcox, 2022, PloS one.

Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort

M. Gravenor, J. Halcox, A. Lacey, 2019, Journal of the American Heart Association.

Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study.

M. Gravenor, A. Chase, J. Halcox, 2020, European journal of preventive cardiology.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study.

M. Gravenor, A. Chase, J. Halcox, 2021, European journal of preventive cardiology.

Repair of a sinus of valsalva aneurysm that had ruptured into the pulmonary artery.

H. Luckraz, Geraint Jenkins, M. Naik, 2004, The Journal of thoracic and cardiovascular surgery.

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Benjamin R. Szwejkowski, J. McMurray, I. Matthews, 2022, The Lancet.

Predictors of 1- and 12-month mortality in bifurcation coronary intervention: a contemporary perspective.

A. Hailan, A. Chase, A. Choudhury, 2023, Future cardiology.